Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Jun 24, 2020 10:06pm
121 Views
Post# 31188728

RE:RE:RE:elgin1 - ViaCyte & SVA

RE:RE:RE:elgin1 - ViaCyte & SVA“ Capable “ and actually being able to produce c peptide in significant amounts that’s clinically relevant in reducing insulin in patients are two different things. I am also “ capable” of flying by flapping my arms up and down but unlikely .

Viacyctes new chaiperson of their board has been fired from Vertex for questionable personal choices . Might as well have Bill Cosby or Weinstein on the board then.

Did you notice J and J and no big pharma participated in their last raise of 27 million dollars ? 

My bet is that big  pharma is no longer looking at Viacycte .  They definitely stopped funding them now imo.

Bioteck take it easy on Sonny . Focus on the 12500 share man .


Bullboard Posts